GC-Carnitine Injection (L-Carnitine)

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic disorders due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2 ~ 3 grams of L-carnitine per day in 2 ~ 3 divided doses by intramuscular or intravenous injection. Adjust the dose as appropriate according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10 ~ 20 milligrams / kilogram intravenously over 2 ~ 3 minutes at the end of each hemodialysis session. The dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

Caution should be taken when opening the ampoule for injection as glass fragments may mix. Extra care is needed when used with children or the elderly. People allergic to this medication should not use it. Transient nausea or vomiting may occur during use, and in rare cases, unusual body odors or symptoms of gastritis may appear. Individuals with a history of seizures should be cautious as seizures may occur more frequently or severely. Various side effects have been reported in chronic hemodialysis patients, including abdominal pain, allergic reactions, headache, infections, injection site pain, arrhythmias, changes in blood pressure, digestive issues, blood abnormalities, weight changes, myalgia, neurological symptoms, respiratory issues, and skin rashes. Pregnant women or those who may be pregnant should only use this medication if the therapeutic benefit is deemed greater than the risk. Additionally, breastfeeding women should use it cautiously as there is a possibility of the drug being transmitted through breast milk.

• Transient area
• vomiting
• body odor
• gastritis
• seizures
• abdominal pain
• accidental injury
• allergic reaction
• asthma
• low back pain

This medication is sensitive to light and should be stored in a tightly closed container that blocks light. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help to preserve the efficacy and safety of the medication over time.

Appearance

Brown ampoules containing a clear colorless to pale yellow liquid

Package unit

50 ampoules/box [(5 milliliters/ampoule)]